Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?
使用佐贝妥昔单抗治疗的 Claudin 18.2 阳性胃癌的诊断和治疗挑战：患者内部异质性还是继发性表达丧失？
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-026-06447-3
Morath, O; Lindig, U; Katenkamp, K; Gassler, N; Haziri, D; Auletta, V; Bauerschlag, D; Franiel, T; Bergener, M; Griessbach, A S; Ernst, T; Hochhaus, A; Crodel, C C
